Insight Molecular Diagnostics IMDX Rallies 575 as Bullish Momentum Builds Near Key Resistance Fate Therapeutics Rallies 95 as FATE Stock Breaks Above Key Support Level Voya Global Equity Dividend and Premium Opportunity Fund IGD Edges Lower Testing Key Support Levels Foxx Development Holdings FOXX Plunges Nearly 16 as Selling Pressure Intensifies